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In-hospital 
Procedural s”ccess (%) 98.7 99.1 NS 
MACE at 30 days (%) 0 0 
Lesion Length (mean: mm) 22.6 24.5 NS 
Reference diameter (mean: mm) 2.72 2.83 NS 
Post MLD (mean: mm) 2.20 2.73 p.zo.05 
p<o.o5 
pco.05 
pco.05 
p<o.o5 
Angiogaraphic follow-up at 6 months 
Follow-upMLD (mean: mm) 
Restenosis (%) 
TLR (%) 
Event free suwival (12 months) (%) 56.9 71.5 
CB ROta 
(Il=450) (n=432) 
1.55 
41.6 
32.6 
2.03 
27.6 
20.6 
P 
MACE: Major Adverse Cardiac Event (death / CABG I Ml: Myocardial Infarction) 
MLD: Minimum Lumen Diameter 
TLR: Target Lesion Revascularizatlon 
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In-stent restenosis remains a major problem after coronary stenting. The Cutting Bal- 
loonTM (CB) is a new device which has shown promise in the reduction of in-stent rest- 
enosis. We report here interim results of the REDUCE Ill study; a prospective, 
randomized, multi-center trial to investigate the safety and effectiveness of CB angio- 
plasty followed by stenting, compared to Plain Old Balloon Angioplasty (POBA) followed 
bv stentina, for the reduction of in&ant restenosis. Method: A total of 523 patients were _ 
randomized to either CB angioplasty or POBA, followed by stentlng. Patients underwent 
follow-uo anaioarams at 6 months. Pnmarv endooint was TLR at 6 month follow-uo. 
Results; Analysis for the initial 261 patient: has been completed (CB: 135 pts. POBA: 
146 pts). There were no differences in patient or lesion characteristics; coronary risk fac- 
tors, including diabetes mellitus (CB: 71/260, 27.3%; POBA: 671262, 33.2%); or in proce- 
dural success rates (CB 99.2% vs. POBA 96.4%). The preliminary analysis for the initial 
261 patients shows no significant difference as yet for TLR (CB: 14/135, 10%; POBA: 201 
146, 17%; p = 0.07); however, TLR tends to be higher for POBA than CB. Conclusion: 
CB angioplasty followed by stenting seems to decrease TLR. The final QCA data results 
will be presented at the next meeting. 
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Background: The incidence of late major adverse cardiac events after vascular brachy- 
therapy is higher than in controls. Because expansive remodeling has been shown to 
correlate with a poor clinical outcome after vascular interventions, we studied adventitial 
changes and arterial remodeling after intravascular irradiation in an animal model of rest- 
enosis. 
Methods: Twenty nonolipidemic rabbits underwent balloon Injury in both external iliac 
arteries. One artery was randomly assigned for subsequent irradiation with an 9OY 
sowce (15 Gy or 30 Gy at 0.5 mm in the vessel wall). After 4 weeks morphometnc mea- 
surements were performed and cell density, collagen amount, and the extent of alterial 
remodeling were determined. Staining for Ki67 identified proliferating cells: apoptotic 
cells were identified by in situ end-labeling of fragmented DNA, and indices were calcu- 
lated as positive cells/total cell count x100. 
Results: The neointlmal area decreased to 0.27*0.3mm2 after irradiaiion vs. 
0.5550.2mm2 in controls (p=O.O07), whereas the adventitia increased from 
0.62+0.3mm2 to 0.67+0.3mm2 (~~0.02). The expansive remodeling observed after irra- 
diation correlated directly with the adventitlal area (p<O.OOOl, r=0.63) and inversely with 
neointimal area (p=O.OOOl, rz0.57). Irradiation reduced the proliferative (0.95+2.6 vs. 
3.73t4.7, p=O.O26) and the apoptotic Index (0.006iO.02 vs. 0.107+0.2. p=O.O3) in the 
neointima, but not in the other arterial wall layers. There was no difference between 15 
and 30Gy in any of the parameters, although adventitial thickening was mole pro- 
nounced in the high-dose group 
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Conclusion: The occurrence of adventitial thickening and expanwe remodeling after 
intravascular irradiation might explain the increased incidence of late MACE after coro- 
nary brachytherapy. 
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Background: Contrast induced nephropathy (GIN) IS a common cause of renal failure 
and correlates with higher in-hospital and late mortality after percutaneous coronary 
intervention (PCl).Obiective: To develoo a simole risk score that has broad apolicabilitv. . 
is easily calculated at presentation, and identifies pts with different responses to contrast 
exoosure. Methods: The Cardiovascular Research Foundation 1CRFI orosoective data- 
base was probed to identify 9726 consecutive pts undergoing PCI. Univariate predictors 
for CIN (defined as 25% rise in baseline creatinlne) were identified. The risk score was 
derived by selection of Independent prognostic variables using multivanate logistic 
regression. Assignment of value of 1 when a factor was present and 0 when it was 
absent, and summing the number of factors present to categorize patients into risk strata. 
Results: The eight risk score predictor variables were: Chronic renal failure ((X2.0 mg/ 
dl, or creatinine clearance <40cc/min), age > 70 yrs, diabetes mellitus, female gender, 
left ventricular ejection fraction < 40%, acute coronary syndrome presentation, contrast 
volume >15Occ, and IABP use. lncldence of CIN increased significantly as the risk score 
increased I” this cohort.(Figure). Conclusion: In pts undergoing PCI, the CRF risk score 
is a simple prognostic scheme that categorizes a pt’s risk of CIN and provides a basis for 
important modifications in the procedural related factors which are controlled by the oper- 
ator (ie: contrast volume). 
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Background: lntracoronaly radiation therapy (IRT) has become the treatment strategy 
of choice for in-stent restenosis (ISR). However, its role I” totally occluded ISR lesions 
has been poorly characterized. The objective of this study was to evaluate the safety and 
long-term efficacy of gamma IRT in patients with totally occluded ISR lesions.Methods 
and Results: Six hundred and sixty nine consecutive patlents (pts) were selected from 
the WRIST (Washington Radiation for In-Stent Restenosis Trial) series of gamma IRT tri- 
als designed to assess the role of IRT for ISR. Of the total cohort, 66 (12.9%) pts had 
totally occluded (TO) ISR and had similar demographic and procedural characteristics to 
587 pts with non-total occlusion (NTO) ISR. Six-month clinical and angiographic out- 
comes were equivalent in both groups (Table). Eighty-two (95%) patients with TO ISR 
had successful recanalization with conventional percutaneous coronary intervention. 
TO ISR (N&2) NT0 ISR (N=587) P 
Late Loss, mm 0.6 * 0.9 0.4 * 0.7 0.12 
Angiographic Binary Restenosis, % 32 21 0 12 
Death, % 4 3 0.71 
Q-wave Myocardial Infarctton, % 3 1 0.36 
Target Lesion Revascularizatlon, % 2U 20 0.95 
Target Vessel Revascularization. % 24 28 0.41 
Late Thrombosis, % 6 4 0.13 
Major Adverse Cardiac Events, % 21 22 0.92 
Conclusions: Gamma IRT for ISR with total occlusion is feasible, safe, and associated 
with comparable outcomes as non-occlusive ISR. Totally occluded ISR lesions should 
become an important indication for gamma intracoronary radiation. 
